Urinary tract infection (UTI) is one of the most common causes of bacterial infection in the rural part of Bangladesh. Bacterial prevalence and their antibiotic resistance patterns in rural coastal region might be different due to high salt concentration in household water. This study demonstrates the prevalence of urinary pathogens and their antibiotic resistances isolated from community individuals in two coastal areas (Shyamnagar-22°20'14.2764''N and 89°6'31.1400''E ; Paikgachha-22°35'20.04"N and 89°20'9.96"E) of Bangladesh. In this study, urine samples were collected from 116 individuals using mid-stream clean-catch method. Bacterial identification and antibiotic resistance were observed using standard laboratory procedure. The prevalence of UTI was 9% (5 out of 55) in males and 20% (12 of 61) in females, although asymptomatic bacteriuria was 93% (108 of 116) in all studied individuals. Among the isolates, 69% (n=80) were Escherichia coliof which 69% (55 of 80) were multidrug resistant (MDR). Staphylococcus saprophyticus was present in 50% (n=58) and Enterobacter aerogenesin 28% (n=32) individuals of which 60% (18 of 30) and 91% (3 of 32) had MDR strains respectively. The prevalence of other bacteria were as follows: 21% (n=24) P. aeruginosa,17%(n=20) S. aureus, 11% (n=13) K. pneumonia and Staphylococcus spp. each, 7% (n=8) Citrobacter sp., and 2% (n=2) Salmonella sp.The MDR rates were 83% (20 of 24) in P. aeruginosa, 80% (16 of 20) in S. aureus, 85% (11 of 13) in K. pneumonia and 60% (3 of 5) in Staphylococcus spp. Furthermore, the resistance rates against fluoroquinolone and third generation cephalosporin were also abundant; 52% and 40% in Escherichia coli, 43% and 23% in Staphylococcus saprophyticus, 38% and 44% in Enterobacter aerogenes, 31% and 23% in K. pneumonia respectively. These results suggest that resistance to common antibacterial drugs is already quite significant in the study population and most likely will grow with time, which warrants area-specific monitoring data for choosing efficacious and empirical treatment for UTIs. Healthcare practitioners should also be aware of potential treatment failure.